Taxus Cardium Pharmaceuticals Group Inc (CRXM)

[bentleyt]

lakes.....You Are Right.....Many Years And Many Millions Of Dollars Spent Developing Generx.....Combined Studies For Generx Included 650 Patients At Over 100 Medical Centers.....We Are Now At The "Sweet Spot" With A Fast Track Phase 3.....The Last Quarter Ended June 30 2021.....The Filings Will Include That Quarter.....Gene Biotherapeutics Has Expressed That They Will Be Timely.....Patient Investors Should See 20.....30.....40 Fold Gains And Even Better As Milestones Are Achieved IMHO!